TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←

IDEL (Gen Bio AI)

private
sign in to save

IDEL (Gen Bio AI) is a privately held company tracked for investment-relevant business and technology developments.

sentiment mix
bull 100%bear 0%neu 0%

funding rounds

private markets
awaiting round data

This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.

signal summary

latest high-conviction thesis
Salem: IDEL cell simulation turns biology into software engineering problem▾

Cell simulation provides the 'comprehension' layer for biology's language, turning 50 trillion human cells into a navigable software problem; combined with reading (sequencing) and writing (CRISPR/mRNA), this completes the biology-as-information stack.

salim ismailT2Peter H. Diamandis2026-08-21
confidence 78 / 100impact High
key themes
  • Memory & Storage100%
  • AI Drug Discovery100%
  • AI Infrastructure100%
  • Frontier AI Models100%
  • AI Agents100%

bull thesis · 2

91 / 100
  • •Salem: IDEL cell simulation turns biology into software engineering problem
  • •Alex: IDEL virtual cell simulator means 'medicine is cooked' - end of disease via in silico simulation

bear thesis · 0

—
  • — none —

mentions · 2

Peter H. DiamandisElon Says 100X, Memory Prices Spike 500%, Unitree Robot Outruns Usain Bolt with Emad Mostaque | #2822 mentions · 2▲ 0▼ 0○ · last month
0:0036:001:12:001:48:002:25:00